| Intervention Category | Mean Percent* (95% CI) | Forecast Percent† (95% CI) | |
|---|---|---|---|
| Pharmacological | BTX (B) | 66.6 (43.7, 83.7) | 66.6 (15.6, 95.6) |
| Anticholinergic (C) | 49.4 (37.3, 61.5) | 49.4 (9.4, 90.2) | |
| Periurethral Bulking (U) | 42.1 (14.6, 75.7) | 42.1 (5.0, 90.9) | |
| Alpha Agonist (A) | 41.6 (30.2, 54.1) | 41.6 (7.0, 87.0) | |
| Anticholinergic + Hormones (C+H) | 25.2 (5.4, 66.6) | 25.2 (2.0, 84.9) | |
| Hormones (H) | 14.9 (6.2, 31.7) | 14.9 (1.6, 65.7) | |
| Nonpharmacological | Neuromodulation + Behavioral Therapy (N+T) | 68.7 (46.9, 84.6) | 68.7 (17.1, 95.9) |
| Behavioral Therapy (T) | 64.1 (53.8, 73.2) | 64.1 (16.1, 94.3) | |
| Intravesical Pressure Release (V) | 60.2 (24.6, 87.6) | 60.2 (9.5, 95.6) | |
| Neuromodulation (N) | 58.0 (46.9, 68.3) | 58.0 (12.9, 92.8) | |
| Combination | Hormones + Neuromodulation + Behavioral Therapy (H+N+T) | 71.0 (42.4, 89.0) | 71.0 (16.8, 96.7) |
| Anticholinergic + Behavioral Therapy (C+T) | 63.7 (35.3, 84.9) | 63.7 (12.8, 95.4) | |
| No treatment | Placebo/Sham/No Treatment (P) | 24.8 (19.4, 31.2) | 24.8 (3.5, 75.0) |
Intervention category codes are in parentheses, corresponding with the associated figure.
Abbreviations: BTX = onabotulinum toxin A, CI = confidence interval.
The summary mean percentage (with confidence interval) of women in the trials receiving the intervention with the outcome.
The predicted percentage (with confidence interval) of women who receive the intervention in future trials, or in similar settings, who will have the outcome.
From: Results
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.